Hostname: page-component-848d4c4894-xfwgj Total loading time: 0 Render date: 2024-06-15T19:53:42.187Z Has data issue: false hasContentIssue false

A new surface-antigen-adsorbed influenza virus vaccine II. Studies in a volunteer group

Published online by Cambridge University Press:  15 May 2009

C. W. Potter
Affiliation:
Academic Division of Pathology (Virology), University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2 RX
R. Jennings
Affiliation:
Academic Division of Pathology (Virology), University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2 RX
C. McLaren
Affiliation:
Academic Division of Pathology (Virology), University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2 RX
Dorothy Edey
Affiliation:
Academic Division of Pathology (Virology), University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2 RX
C. H. Stuart-Harris
Affiliation:
Academic Division of Pathology (Virology), University of Sheffield Medical School, Beech Hill Road, Sheffield S 10 2 RX
Margaret Brady
Affiliation:
Evans Biologicals Ltd, Speke, Liverpool L24 9JD
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A group of 23 volunteers were each inoculated with 600 CCA of a new form of influenza virus A/England/42/72 vaccine; this vaccine consisted of purified haemagglutinin and neuraminidase antigens adsorbed to alhydrogel. No significant reactions to the vaccine were reported. Twenty-two volunteers produced increased titres of serum HI antibody, and all showed increased titres of NI antibody after immunization. Thus, for volunteers with no pre-immunization serum HI antibody, the geometric mean titre of serum antibody increased from 1/5 to 1/196 after immunization. Ten volunteers developed local neutralizing antibody after immunization; this antibody response was detected most frequently in volunteers who showed the greater serum antibody response to immunization, and in nasal washings with the higher concentrations of protein and IgA. Ten weeks after immunization, the vaccinees and a group of matched controls were inoculated intranasally with attenuated A/England/42/72 virus. Evidence of infection with the challenge virus was found in 14 of the control subjects and in one of the vaccinees. The results indicate that the surface-antigen-adsorbed vaccine induced high titres of serum antibody, and gave significant protection against challenge infection.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1975

References

REFERENCES

Aymard-Henry, M., Coleman, M. T., Dowdle, W. R., Laver, W. G. & Webster, R. G. (1973). Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bulletin of the World Health Organization 48, 199202.Google ScholarPubMed
Bevan, A. (1974). An automated method for measuring neuraminidase and neuraminidase-inhibiting antibody. Symposium on Immunity to Infections of the Respiratory System in Man and Animals, London, 1974. Symposium Series Immunobiological Standards (in the Press).Google Scholar
Bradstreet, C. M. P. & Taylor, C. E. D. (1962). Technique of complement-fixation test applicable to the diagnosis of virus diseases. Monthly Bulletin of the Ministry of Health and the Public Health Laboratory Service 21, 96104.Google Scholar
Brand, C. M. & Skehel, J. J. (1973). Crystalline antigen from the influenza virus envelope. Nature, New Biology 238, 145–7.Google Scholar
Brandon, F. B., Barrett, C. D. Jr., Hook, A. E. & Lease, G. O. (1967). Human febrile response to influenza virus or its ether isolated haemagglutinins. Proceedings of the Society for Experimental Biology and Medicine 125, 683–6.CrossRefGoogle ScholarPubMed
Davenport, F. M., Hennessy, A. V., Brandon, F. B., Webster, R. G., Barrett, C. D. Jr. & Lease, G. O. (1964). Comparisons of serological and febrile responses in humans to vaccination with influenza A viruses or their haemagglutinins. Journal of Laboratory and Clinical Medicine 63, 513.Google ScholarPubMed
Davenport, F. M. (1968). Antigenic enhancement of ether-extracted influenza virus vaccines by AIPO4. Proceedings of the Society for Experimental Biology and Medicine 127, 587–90.CrossRefGoogle ScholarPubMed
Davenport, F. M., Hennessy, A. V. & Askin, F. B. (1968). Lack of adjuvant effect of AIPO4 on purified influenza virus haemagglutinins in man. Journal of Immunology 100, 1139–40.CrossRefGoogle Scholar
Downie, J. C. & Stuart-Harris, C. H. (1970). The production of neutralizing activity in serum and nasal secretion following immunization with influenza B virus. Journal of Hygiene 68, 233–44.CrossRefGoogle ScholarPubMed
Fahey, J. L. & McLaughlin, C. (1963). Preparation of antisera specific for 6·6 S γ-globulins, β2A-globulins, γ-macroglobulins and for type I and II common γ-globulin determinants. Journal of Immunology 91, 484–97.CrossRefGoogle Scholar
Fazekas De St Groth, S., Witchell, S. J. & Lafferty, K. J. (1958). An improved assay for neutralization antibodies against influenza viruses. Journal of Hygiene 56, 415–26.CrossRefGoogle Scholar
Fenters, J. D., Yamashiroya, H. M., Petzold, R. F. & Tolkacz, V. K. (1970). Enhanced immunogenicity in mice of a purified, tween-ether-treated influenza vaccine. Applied Microbiology 20, 544–50.CrossRefGoogle ScholarPubMed
Hennessy, A. V. & Davenport, F. M. (1966). Relative antigenic potency in man of polyvalent influenza virus vaccines containing isolated haemagglutinins or intact viruses. Journal of Immunology 97, 235–8.Google Scholar
Hennessy, A. V. & Davenport, F. M. (1974). Studies on vaccination of infants against influenza with influenza haemagglutinin. Proceedings of the Society for Experimental Biology and Medicine 146, 200–4.CrossRefGoogle Scholar
Jennings, R., Potter, C. W., McLaren, C. & Brady, M. (1975). A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters. Journal of Hygiene 75, 341–52.CrossRefGoogle ScholarPubMed
Kilbourne, E. D., Chanock, R. M., Choppin, P. W., Davenport, F. M., Fox, J. P., Gregg, M. B., Jackson, G. G. & Parkman, P. D. (1974). Influenza vaccines—Summary of Influenza Workshop V. Journal of Infectious Diseases 129, 750–71.CrossRefGoogle Scholar
Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265–75.CrossRefGoogle ScholarPubMed
Mancini, G., Carbonara, A. O. & Heremans, J. F. (1965). Immuno-chemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 25, 235–54.CrossRefGoogle Scholar
McLaren, C., Potter, C. W. & Jennings, R. (1974). Immunity to influenza in ferrets. XII. Immunization of ferrets with TNBP-split influenza virus vaccines. Archiv für die gesamte Virusforschung 45, 99105.Google Scholar
Neurath, A. R., Rubin, B. A., Sillaman, J. & Tint, H. (1971). The effect of nonaqueous solvents on the quaternary structure of viruses: a procedure for the simultaneous concentration, purification and disruption of influenza viruses. Microbios 4, 145–50.Google Scholar
Quilligan, J. J., Francis, T. Jr. & Minuse, E. (1949). Reactions to an influenza virus vaccine in infants and children. American Journal of Diseases of Children 78, 295301.Google Scholar
Reed, L. J. & Muench, H. (1938). A simple method for estimating 50 per cent end points. American Journal of Hygiene 27, 493–7.Google Scholar
Ruben, F. L. & Jackson, G. G. (1972). A new subunit influenza vaccine: acceptibility compared with standard vaccines and effect of dose on antigenicity. Journal of Infectious Diseases 125, 656–64.CrossRefGoogle Scholar
Ruben, F. L., Potter, C. W. & Stuart-Harris, C. H. (1975). Humoral and secretory anti-body responses to immunization with low and high dosage split influenza virus vaccine. Archives of Virology 47, 157–66.CrossRefGoogle Scholar
Sever, J. L. (1962). Application of a microtechinique to viral serological investigations. Journal of Immunology 88, 320–9.CrossRefGoogle ScholarPubMed
Webster, R. B. & Laver, W. G. (1966). Influenza virus subunit vaccines: Immunogenicity and lack of toxicity for rabbits of ether and detergent-disrupted virus. Journal of Immunology 96, 596605.Google Scholar
Zavadova, H., Vonka, V., Adam, E., Domorazkova, E. & Davenport, F. M. (1972). Clinical reactions, haemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3–6, 7–17 and 17–50 years. Archiv für die gesamte Virusforschung 36, 4352.Google Scholar